Protecting and advancing CRNA practice in California.
CANA's advocacy team represents California's nurse anesthetists in the Capitol, with state agencies, and inside the institutions that govern our scope. We defend the opt-out, protect CRNA practice authority, and make sure our voice is in every room where anesthesia policy is written.
Practice questions, authoritatively answered.
CANA maintains a living reference for the questions California CRNAs actually ask — scope, supervision, authority, billing, and the standardized-procedure framework. Searchable, sourced, and kept current by the Practice Committee.
Policy changes when CRNAs show up.
Grassroots is how CRNAs make sure the people making decisions about our practice have heard from the people doing the work.
Advocacy News & Updates
California Association of Nurse Anesthesiology Hosts 2025 Opioid Epidemic Symposium: Identifying Obstacles, Inspiring Solutions
For it’s first ever CRNA Week Symposium, CANA brought together legislators, health care experts, policymakers, and community advocates to tackle one of California’s most pressing public health challenges. CANA’s 2025 Opioid Epidemic Symposium: Identifying Obstacles, Inspiring Solutions featured powerful testimonials, practical strategies, and innovative approaches to help address the crisis in California, including the role of Certified Registered Nurse Anesthesiologists (CRNAs) in providing opioid-free pain management techniques.
Read MoreAssemblymember Flora Responds to CMS immediate jeopardy guidelines
—Assemblymember Heath Flora (R-Ripon) today issued the following statement in response to revised guidance by the Centers for Medicare & Medicaid Services (CMS) for surveyors and health care providers regarding immediate jeopardy.
Read MoreCRNAs are essential for safe and timely anesthesia care in California
Certified Registered Nurse Anesthetists (CRNAs) play an indispensable role in California’s health care system, particularly for underserved and rural communities where anesthesia access is critical, yet limited.
Read More